Follicum's new topical formulation of FOL-005 results in increased hair growth on a par with leading commercial product
Follicum AB ("Follicum" or "company") today reports results for lead candidate FOL-005 in an in vivo-model for hair growth. The study examined hair growth in test animals after treatment with the new creamlike topical formulation of FOL-005 at three different doses. Applied once a day and after about one week of treatment, growth of new hair was observed. The study shows that treatment with Follicum's newly developed formulation results in good hair growth comparable to that of minoxidil, a leading commercial product. The best effect was seen with the highest dose and a clear dose response